Nexentis Technologies/$NXTS
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Nexentis Technologies
Nexentis Technologies Inc, is engaged in redefining mitochondrial drug discovery with help of its wholly owned biotechnology subsidiary, MitoCareX Bio focused on drug discovery company dedicated to developing first-in-class therapeutics for inflammatory metabolic diseases and cancer by targeting specific metabolic pathways. The company is also focused on sustainable operations in various industries such as solar projects, and oncology biotechnology.
Ticker
$NXTS
Sector
Primary listing
Employees
8
Headquarters
Ness Ziona, Israel
Website
NXTS Metrics
BasicAdvanced
$3.6m
-
-$31.47
-
-
Price and volume
Market cap
$3.6m
52-week high
$6.25
52-week low
$3.38
Average daily volume
37k
Financial strength
Current ratio
4.726
Quick ratio
3.639
Long term debt to equity
0.848
Total debt to equity
3.678
Profitability
EBITDA (TTM)
-6.99
Effective tax rate (TTM)
0.41%
Management effectiveness
Return on assets (TTM)
-37.56%
Return on equity (TTM)
-119.61%
Valuation
Price to book
0.28
Price to tangible book (TTM)
0.41
Price to free cash flow (TTM)
-0.305
Free cash flow yield (TTM)
-328.12%
Free cash flow per share (TTM)
-16.078
Growth
Earnings per share change (TTM)
-90.28%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs